Effect of administration mode (patient vs physician) and patient's educational level on the Turkish version of the International Prostate Symptom Score

International Journal of Urology

Volumn 9, Issue 8, 2002, Pages 417-421

  Bozlu, M ^b   Doruk, E ^a   Akbay, E ^a   Ulusoy, E ^a   Cayan S ^a   Acar, D ^a   Kanik, E A ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b NONE

Author keywords

Education; International Prostate Symptom Score; Mode of administration; ROC curves

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; ROC CURVE; SCORING SYSTEM; TURKEY (REPUBLIC);

ADULT; AGED; EDUCATIONAL STATUS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 0036379767     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00491.x     Document Type: Article

References (25)

1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469-71.
2. Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: A population-based survey of urinary symptoms. J. Urol. 1993; 150: 85-9.
3. Garraway WM, Kirby RS. Benign prostatic hyperplasia: Effects on quality of life and impact on treatment decisions. Urology 1994; 44: 629-36.
4. Reynard J, Abrams P. Symptoms and symptoms score in BPH. Scand. J. Urol. Nephrol. 1994; 157: 137-45.
5. Kaplan SA, Olsson CA, Te AE. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work? J. Urol. 1996; 155: 1971-4.
6. Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J. Urol. 1992; 148: 1549-57.
7. Lukacs B, McCarthy C, Leplege A, Comet D. Development and validation of quality of life scale associated with health status specific for benign hypertrophy of the prostate and including a sexuality evaluation scale. French Prog. Urol. 1994; 4: 688-99.
8. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J. Urol. 1995; 153: 669-73.
9. Blackman NJ, Koval JJ. Interval estimation for Cohen's kappa as a measure of agreement. Stat. Med. 2000; 19 (5): 723-41.
10. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
11. Denis L, McConnell J, Yoshida O et al. 4th International Consultation on BPH. Recommendations of the International Scientific Committee: The evaluation and treatment of lower urinary symptoms (LUTS) suggestive of benign prostatic obstruction. In: Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH). Denis L, Griffiths K, Khoury S (eds). Plymouth, Plymbridge Distributors, 1998; 669-84.
12. Boyle P. Cultural and linguistic validation of questionnaires for use in international studies: The nine-item BPH-specific quality of life scale. Eur. Urol. 1997; 32: 50-2.
13. O'Leary M. The importance of standardisation and validation of symptom scores and quality of life: The urologist's point of view. Eur. Urol. 1997; 32: 48-9.
14. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993; 42: 36-40.
15. Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: Lack of index specificity for benign prostatic hyperplasia. J. Urol. 1993; 150: 1706-8.
16. Chai TC, Belville WD, McGuire EJ, Nyquist L. Specificity of the American Urological Association voiding symptom index: Comparison of unselected and selected samples of both sexes. J. Urol. 1993; 150: 1710-3.
17. Badia X, Garcia-Losa M, Dal-Ré R. Ten-language translation and harmonization of the international prostate symptom score: Developing a methodology for multinational clinical trials. Eur. Urol. 1997; 31: 129-40.
18. Barry MJ, Fowler FJ, Chang Y, Liss CL, Wilson H, Stek M Jr. The American Urological Association symptom index: Does mode of administration affect its psychometric properties? J. Urol. 1995; 154: 1056-9.
19. Plante M, Corcos J, Gregoire I, Belanger MF, Brock G, Rossingol M. The International Prostate Symptom Score. Physician versus self-administration in the quantification of symptomatology. Urology 1996; 47: 326-8.
20. Rhodes T, Girman CJ, Jacobsen SJ, et al. Does the mode of questionnaire administration affect the reporting of urinary symptoms? Urology 1995; 46: 341-5.
21. Netto NR Jr, de Lima ML. The influence of patient education level on the International Prostatic Symptom Score. J. Urol. 1995; 154: 97-9.
22. Moon TD, Brannan W, Stone NN et al. Effect of age, educational status, ethnicity and geographic location on prostatic symptom scores. J. Urol. 1994; 152: 1498-500.
23. Koyanagi T, Artibani W, Correa R et al. Initial diagnostic evaluation of men with lower urinary tract symptoms. In: Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH). Denis L, Griffiths K, Khoury S et al. (eds). Plymouth, Plymbridge Distributors, 1998; 181-264.
24. Jepsen JV, Bruskewitz RC. Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998; 51 (Suppl. 4A): 13-8.
25. Neal DE, Ramsden PD, Sharples L, Smith A, Powell PH, Styles RA, Webb RJ. Outcome of elective prostatectomy. BMJ 1989; 299: 762-7.